Cytosolic DNA is prevalent in cells constituting the tumor microenvironment(TME)and can activate the cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)-stimulator of interferon genes(STING)innate im...Cytosolic DNA is prevalent in cells constituting the tumor microenvironment(TME)and can activate the cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)-stimulator of interferon genes(STING)innate immune pathway.The initiation,transmission,and execution of the cGAS-STING pathway can take place among different cell types within the TME and thus cGAS-STING may play opposing roles in driving tumor progression in addition to its tumor cell-intrinsic role.Herein,we review recent advances in the cGAS-STING field with a focus on its crosstalk with other signaling pathways in the TME.Future efforts to depict a more detailed picture of the roles of cGAS-STING signaling in the TME wil help design a better cancer treatment regime by targeting the cGAS-STING pathway more precisely.展开更多
The“six-and-twelve”(6&12)score is a new hepatocellular carcinoma(HCC)prognostic index designed for recommended transarterial chemoembolization(TACE)candidates.Quick and easy to use by the sum of tumor size(cm)an...The“six-and-twelve”(6&12)score is a new hepatocellular carcinoma(HCC)prognostic index designed for recommended transarterial chemoembolization(TACE)candidates.Quick and easy to use by the sum of tumor size(cm)and number,this model identifies three groups with different survival time(the sum is≤6;or>6 but≤12;or>12);a survival benefit with TACE can be expected for HCC patients with a score not exceeding twelve.Recently,Wang ZW et al showed that the“6&12”model was the best system correlated with radiological response after the first TACE.Thus,we wanted to assess its survival prediction ability as well as its prognostic value and compared it to other systems(Barcelona Clinic Liver Cancer,Hong Kong Liver Cancer(HKLC)staging,Albumin-Bilirubin grade,tumor nodularity,infiltrative nature of the tumor,alpha-fetoprotein,Child-Pugh class,and Performance Status score,Cancer of the Liver Italian Program,Model to Estimate Survival for HCC scores,up-to-seven criteria)different from Wang ZW et al study in a multicenter French cohort of HCC including only recommended TACE candidates retrospectively enrolled.As previously demonstrated,we show that the"6&12”score can classify survival within this French cohort,with a prognostic value comparable to that of other systems,except HKLC staging.More importantly,the“6&12”score simplicity and ability in patients’stratification outperform other systems for a routine clinical practice.展开更多
基金supported by the High-Risk High-Reward Program from the Office of the Director,National Institutes of Health(DP50D026395)the National Cancer Institute(Breast Cancer SPOREP50CA247749 and R01CA256188-01)+4 种基金the Department of Defense Congressionally Directed Medical Research Program,the Burroughs Wellcome Fund Career Award for Medical Scientiststhe Parker Institute for Immunotherapy at MSKCC,the Josie Robertson Foundation,the STARR Cancer Consortium,the Cycle for Survival Fundthe MSKCC core grant(P30-CA008748)the National Institutes of Health/National Cancer Institute MSK Genomic Instability in Breast Cancer SPORE P50CA247749the Translational Research Oncology Training Program(T32 CA 160001).
文摘Cytosolic DNA is prevalent in cells constituting the tumor microenvironment(TME)and can activate the cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)-stimulator of interferon genes(STING)innate immune pathway.The initiation,transmission,and execution of the cGAS-STING pathway can take place among different cell types within the TME and thus cGAS-STING may play opposing roles in driving tumor progression in addition to its tumor cell-intrinsic role.Herein,we review recent advances in the cGAS-STING field with a focus on its crosstalk with other signaling pathways in the TME.Future efforts to depict a more detailed picture of the roles of cGAS-STING signaling in the TME wil help design a better cancer treatment regime by targeting the cGAS-STING pathway more precisely.
文摘The“six-and-twelve”(6&12)score is a new hepatocellular carcinoma(HCC)prognostic index designed for recommended transarterial chemoembolization(TACE)candidates.Quick and easy to use by the sum of tumor size(cm)and number,this model identifies three groups with different survival time(the sum is≤6;or>6 but≤12;or>12);a survival benefit with TACE can be expected for HCC patients with a score not exceeding twelve.Recently,Wang ZW et al showed that the“6&12”model was the best system correlated with radiological response after the first TACE.Thus,we wanted to assess its survival prediction ability as well as its prognostic value and compared it to other systems(Barcelona Clinic Liver Cancer,Hong Kong Liver Cancer(HKLC)staging,Albumin-Bilirubin grade,tumor nodularity,infiltrative nature of the tumor,alpha-fetoprotein,Child-Pugh class,and Performance Status score,Cancer of the Liver Italian Program,Model to Estimate Survival for HCC scores,up-to-seven criteria)different from Wang ZW et al study in a multicenter French cohort of HCC including only recommended TACE candidates retrospectively enrolled.As previously demonstrated,we show that the"6&12”score can classify survival within this French cohort,with a prognostic value comparable to that of other systems,except HKLC staging.More importantly,the“6&12”score simplicity and ability in patients’stratification outperform other systems for a routine clinical practice.